Brad Ringeisen

Investor

Scientific Advisory Board - Innovative Genomics Institute at Medical Excellence Capital

About

Scientific advisor and Executive Director of the Innovative Genomics Institute at UC Berkeley. A physical chemist and former DARPA Biological Technologies Office director.

Colleagues at Medical Excellence Capital

Annabel Stoddart

Office Manager and Executive Assistant at Medical Excellence Capital

Brian Halak

Managing Partner at Medical Excellence Capital

Douglas Wallace

Scientific Advisory Board – Director of Center for Mitochondrial and Epigenomic Medicine at Medical Excellence Capital

Eric Heil

Managing Partner at Medical Excellence Capital

Gregg Semenza

Scientific Advisory Board – Professor at Johns Hopkins at Medical Excellence Capital

John Hornbostel

Counsel at Medical Excellence Capital

John Prufeta

Chief Executive Officer and Managing Partner at Medical Excellence Capital

Joni Mancini

Managing Partner at Medical Excellence Capital

Frequently asked questions

Who is Brad Ringeisen?: Scientific advisor and Executive Director of the Innovative Genomics Institute at UC Berkeley. A physical chemist and former DARPA Biological Technologies Office director.
Where does Brad Ringeisen work?: Brad Ringeisen is Scientific Advisory Board - Innovative Genomics Institute at Medical Excellence Capital.